Elanco Animal Health Incorporated Common Stock (ELAN) is a publicly traded Healthcare sector company. As of July 22, 2026, ELAN trades at $25.75 with a market cap of $12.56B and a P/E ratio of -50.99. ELAN moved +1.30% today. Year to date, ELAN is +12.59%; over the trailing twelve months it is +73.57%. Its 52-week range spans $8.02 to $27.72. Analyst consensus is strong buy with an average price target of $29.71. Rallies surfaces ELAN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ELAN, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $25.75 |
| Market Cap | $12.56B |
| P/E Ratio | -50.99 |
| EPS | $-0.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.72 |
| 52-Week Low | $8.02 |
| Volume | 693.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.89B |
| Net Income | $-242.00M |
| Gross Margin | 55.06% |
11 analysts cover ELAN: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $29.71.